Randomized Phase 2 Trial of the Oncolytic Virus Pelareorep (REOLYSIN®) in Upfront Treatment of Metastatic Pancreatic Adenocarcinoma

Noonan, Molecular Therapy vol. 24 no. 6 jun. 2016 1151
Download PDF
View Resource